Blake Insomnia Therapeutics, Inc. announced earnings results for the second quarter ended February 28, 2019. For the second quarter, the company announced net loss was USD 11,588 compared to USD 3,988 a year ago. Basic loss per share from continuing operations was USD 0.36 compared to USD 0.12 a year ago. For the half year, net loss was USD 20,070 compared to USD 7,976 a year ago. Basic loss per share from continuing operations was USD 0.62 compared to USD 0.25 a year ago.